Loading company…
ViewsML develops AI-based virtual biomarker staining for cancer diagnostics and research.
ViewsML uses deep learning to provide virtual biomarker staining for cancer research and diagnostics. Its platform serves pharmaceutical firms, clinical laboratories, and research institutions. Founded in 2022 and based in Vancouver, Canada, the company raised USD 4.90 mn in total, with its latest Seed round led by Wittington Ventures alongside Continuum Health Ventures and Mayo Clinic Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in